Loading
Life sciences · Journal article
International Journal of Environmental Research and Public Health · October 14, 2026
No summary has been generated for this record yet. What follows is drawn from its source metadata only.
Journal article.
No findings were extractable from the material analysed.
Safety was not reported in the material analysed. Check the source before drawing any conclusion about harm.
The source did not state who this applies to in practice.
Graded across the dimensions that decide whether you should act, each from what the source actually supports. There is no single score, and where a dimension was not assessed it says so.
This record has not been graded across any dimension yet. Treat the label above as provisional and read the source.
What is missing. This record has no bottom line, key findings, reported figures, evidence dimensions. That is a gap in the analysis, not a judgement about the study.
Background: Sustaining weight and glycaemic improvements after structured obesity care ends is challenging. This study assessed 6- and 12-month post-intervention outcomes of a nurse practitioner-led interdisciplinary obesity clinic. Methods: In this unblinded randomised controlled trial, 224 rural Australian adults with type 2 diabetes and obesity were allocated to the 24-month AMOS intervention (n = 113) or standard diabetes care (n = 111). Outcomes at 6- and 12-months post-intervention were analysed using mixed-effects linear regression, with multiple imputation for missing data. The trial was registered with the Australian New Zealand Clinical Trials Registry (ACTRN12622000240741). Results: Compared with standard care, the intervention group maintained greater reductions at 6 months post-intervention in body weight (−13.5 kg; 95% CI: −16.8 to −10.1), BMI (−4.6 kg/m2; 95% CI: −5.7 to −3.5) and HbA1c (−0.53 percentage points; 95% CI: −0.97 to −0.09). Differences remained at 12 months for body weight (−11.8 kg; 95% CI: −15.2 to −8.5), BMI (−4.1 kg/m2; 95% CI: −5.2 to −3.0) and HbA1c (−0.75 percentage points; 95% CI: −1.19 to −0.31). Physical quality of life remained higher; other metabolic outcomes were inconsistent. Conclusions: Greater reductions in weight and HbA1c persisted at 12 months after the multidisciplinary AMOS intervention ended, supporting the potential value of integrated obesity treatment within diabetes care.